Studio LegalMark® · Industrial and Intellectual PropertyRome · Zurich · Italy · Switzerland · International
Areas of protection · Life Science

Life Science and Pharmaceuticals. Protect industry assets.

Biotechnology, research and technology transfer. In life sciences, intangible heritage develops through research, experimental results, technologies and collaborations. For biotechs, laboratories and spin-offs, the IP strategy must be linked to the scientific path and technological transfer objectives.

The strategy starts from the project.

Contributions by researchers, institutions and funding partners can be interwoven. A clear document framework helps to distinguish authors, inventors and owners, to identify relevant agreements and to organize the sharing of results before publications or negotiations.

What assets to consider.

Results and technologies

Materials, procedures, tools and applications require a scientific description and a reading of relevant requirements and limits of protection.

Know-how and materials

Protocols, non-public data and material exchanges must be linked to conditions of access, confidentiality and use.

Licensing and spin-off

Research agreements, options and licenses must make readable technological perimeters, territories, uses and economic conditions.

The passage to be guarded

A scientific publication may have effects on the subsequent patent strategy. Before abstracts, posters and presentations it is useful to coordinate the calendar with IP verifications, without assuming that each country applies the same rules on disclosures.

An example of the route.

A spin-off prepares a license on a lab technology. The analysis reconstructs questions and results, relationships with the institution of origin, materials and know-how necessary, distinguishing what is granted by what remains excluded.

Illustrative example: does not describe an assignment or a result obtained by LegalMark.

Useful information for the first comparison.

  • Description of the search and results available
  • Agreements with institutions and financiers
  • Publications provided and disclosures received
  • Titles, materials and licensing objectives

At first it is sufficient to describe the objective and the state of the project. Technical documents and sensitive information can be shared at a later time, after agreeing to the communication methods and perimeter.

From industry to services.

The reading of the project allows you to choose the useful verifications: search on the signs, analysis of the technical solution, organization of the portfolio or preparation of an valorization operation. Priorities, times and territories depend on the concrete structure and activities that the company intends to carry out.

General information content. The forms of protection and any requirements must be verified in the concrete case and in the territories concerned.

Frequently asked question

When to evaluate IP compared to a scientific publication?

Before disclosure. It is appropriate to collect the results, rebuild ownership and contributions and coordinate the scientific calendar with an assessment of the possible forms of protection and the territories.

Talk to LegalMark · Life Science

Tell us about your project.

Indicates the objective and the territories, avoiding to insert technical information reserved in the first message.

If sending fails, please contact us info@legalmark.it

Industry links

Related areas.

All areas of protection →

Sector and territory · Italy

Life Science in Italian regions.

Find the territorial context of your activity and the path of protection. The numbers describe the statistical perimeter indicated, not the application for registration of the marks.

Territorial insights

The dedicated pages cover the five territories with the largest number of local units of the active enterprises observed in the chosen perimeter. The selection measures the variety, not the specialization or the possibility of obtaining a registration.

Life Science · local units of active enterprises · 2023
RegionNumberNational quota
Piedmont8466,04%
Valle d’Aostan.d.n.d.
Liguria3162,26%
Lombardy2.73719,54%
Trentino-Alto Adige2391,71%
Veneto9046,45%
Friuli-Venezia Giulia2701,93%
Emilia-Romagna1.1728,37%
Tuscany9807,00%
Umbria2551,82%
Marche4253,03%
Lazio1.82913,05%
Abruzzo2862,04%
Molise610,44%
Campania1.2919,21%
Apulia6884,91%
Basilicata1190,85%
Calabria3552,53%
Sicily8726,22%
Sardinia3402,43%

Source and data perimeter

ISTAT · ASIA – Local units, flow 183_285_DF_DICA_ASIAULP_2. Year 2023; consultation 11 October 2026. Indicator: local units of active enterprises.

Pharmaceuticals and research in natural sciences and engineering. Proxy: research includes additional disciplines. ATECO 2007: 21, 721.

Reference ISTAT · Method, limits and downloadable data